Table: begin end state 1 19 cytoplasmic 20 40 transmembrane 41 51 non-cytoplasmic 52 71 transmembrane 72 76 cytoplasmic 77 94 transmembrane 95 98 non-cytoplasmic 99 118 transmembrane 119 124 cytoplasmic 125 146 transmembrane 147 172 non-cytoplasmic 173 193 transmembrane 194 204 cytoplasmic 205 227 transmembrane 228 232 non-cytoplasmic 233 253 transmembrane 254 277 cytoplasmic 278 297 transmembrane 298 307 non-cytoplasmic 308 328 transmembrane 329 334 cytoplasmic 335 352 transmembrane 353 357 non-cytoplasmic 358 377 transmembrane 378 384 cytoplasmic
Input: >WP_012405991.1 NCBI__GCF_000020045.1:WP_012405991.1 MTQGQATDWRRLLSLREMGVYYALILLVFVISAVTVYTGRPSYLSLANISNVLYQSSLVA IIAVAMTVILITGNFDLSVASVAALSAAVLVGLADTLGFWPAALVAMLVSVLAGLLNGAI VQYLGINAFIVTLGTLTAIRGVVQIYTDGRSLSVETPEALQAMRLFESGRLPIAIPLILI GAALLFAGIRFLLRARREGRNASPTSLGMIVAGICCLALVYAGGMTLAMPKPVVYMAVFT LIVWFILSMTNIGRRVYAVGGNPEAARLSGINVKRYKMAGFILCSAAAGFGGILFGSRLG AVNPTAMQGAELTVIASAILGGTSLFGGAGSVIKTLAGALLLFTLTNGFNILNLGANYQG VIEGTVVVTAAAIYTVGGSRRGKR
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server